Internal Server Error

Clinigen - About the company

Clinigen is an acquired company based in Burton-on-trent (United Kingdom), founded in 2010. It operates as a Services in clinical trials & medicine supply. Clinigen has raised an undisclosed amount in funding. The company has 1416 active competitors, including 27 funded and 149 that have exited. Its top competitors include companies like CMIC HOLDINGS, IntegriChain and Fishawack.

Company Details

Clinigen Group is a specialty pharmaceutical and services company which consists of five synergistic businesses that provide medicines to patients through clinical trials, licensed and unlicensed routes. Its units include Clinigen Clinical Trial Services (CTS) which provides commercial medicines for patients in clinical trials; Idis Managed Access (MA) which manages early access to unlicensed investigational medicines; Idis Global Access (GA) which enables access to post-approved medicines in regions where they are not commercially available; Clinigen Specialty Pharmaceuticals (SP) which ensures continuity of supply to hospital pharmacists, doctors and patients; and Link Healthcare which provides local and regional commercial access to vitally important specialist Pharmaceutical and Medical Technology products.
Social
X
Email ID
*****@clinigengroup.com
Registered Address
PITCAIRN HOUSE CROWN SQUARE,FIRST AVENUE,BURTON-ON-TRENT,ENGLAND,DE14 2WW
Key Metrics
Founded Year
2010
Location
Burton-on-trent, United Kingdom
Stage
Acquired
Ranked
Employee Count
631 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Acquired by Triton Partners (Dec 08, 2021)

Clinigen's acquisition details

Clinigen got acquired by Triton Partners on Dec 08, 2021 at an acquisition amount of $*****.
Click here to take a look at Clinigen's acquisition in detail
Sign up to download Clinigen's company profile

Clinigen's funding and investors

Clinigen has raised funding over 1 round. Its latest funding round was a Conventional Debt round on 2015 for $*****. 3 investors participated in its latest round. Clinigen has 5 institutional investors.

Here is the list of recent funding rounds of Clinigen:
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
2015
5225
Conventional Debt
2640
7348
8845
3567
lockAccess funding benchmarks and valuations. Sign up today!

Clinigen's founders and board of directors

Founder? Claim Profile

Clinigen's employee count trend

Clinigen has 631 employees as of May 26. Here is Clinigen's employee count trend over the years:
Employee count trend for Clinigen
lockUncover Clinigen's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Clinigen's Competitors and alternates

Top competitors of Clinigen include CMIC HOLDINGS, IntegriChain and Fishawack. Here is the list of Top 10 competitors of Clinigen, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Clinigen
Clinigen
2010, Burton-on-trent (United Kingdom), Acquired
Services in clinical trials & medicine supply
-
59/100
2nd
Logo for CMIC HOLDINGS
CMIC HOLDINGS
1985, Tokyo (Japan), Acquired
Contract service provider for biopharma companies
-
-
58/100
3rd
Logo for IntegriChain
IntegriChain
2005, Philadelphia (United States), Acquired
Pharma commercialization solutions: data, consulting, and technology for market access
$2M
58/100
4th
Logo for Fishawack
Fishawack
2001, Brighton (United Kingdom), Acquired
Provider of fully-integrated, cross-border services to global pharmaceutical organisations
$23.6M
-
57/100
5th
Consulting services for product strategy and decision support
$12.7M
56/100
6th
Logo for Fabtech
Fabtech
2002, Mumbai (India), Public
Provider of instruments for biotech, pharmaceutical, and biomedical industries
$175K
56/100
7th
Logo for Diaceutics
Diaceutics
2005, Belfast (United Kingdom), Public
Analytics based integrator for precision medicine
-
55/100
8th
Logo for Science Group
Science Group
1986, Cambridge (United Kingdom), Public
Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors
-
49/100
9th
Logo for Sequence
Sequence
2002, Morrisville (United States), Acquired
Consulting services provider
-
-
49/100
10th
Logo for Oxford PharmaGenesis
Oxford PharmaGenesis
1998, Oxford (United Kingdom), Acquired
Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector
-
-
48/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Clinigen's competitors? Click here to see the top ones

Clinigen's Investments and acquisitions

Clinigen has not made any investments yet. Clinigen has made 13 acquisitions.
Here is the list of latest three $acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Sep 29, 2025
Acquisition
2010
Parsippany Troy Hills (United States)
Aug 06, 2024
Acquisition
2007
Glasgow (United Kingdom)
Nov 29, 2022
Acquisition
2012
Durham (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all acquisitions by Clinigen

Reports related to Clinigen

Here is the latest report on Clinigen's sector:

News related to Clinigen

lockFilter this list
Media has covered Clinigen for a total of 4 events in the last 1 year, 2 of them have been about people movement.
Clinigen finalises acquisition of SSI StrategyEuropean Pharmaceutical ManufacturerNov 27, 2025Clinigen, SSI Strategy
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Clinigen

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford